– Exicure will reduce its workforce by approximately 50%, along with the implementation of other cost-cutting measures –
– Company to wind down immuno-oncology program cavrotolimod. | December 10, 2021
Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus -Exicure will reduce. | December 10, 2021